What's driving the Antibiotics Market trends? Sanofi, Novartis AG, Pfizer Inc., Bayer AG, Abbott, Eli Lilly and Company. Johnson & Johnson Services, Inc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Astellas Pharma Inc.,

Market Study Report LLC has added a new report on Antibiotics market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also incorporates the regional landscape of Antibiotics market in tandem with its competitive terrain.

The antibiotics was valued at US$ 43,348.38 million in 2019 and is projected to reach US$ 56,351.33 million by 2027; it is expected to grow at a CAGR of 3.6% from 2020 to 2027.

Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/2623844?utm_source=openpr.com&utm_medium=AG

COMPANY PROFILES

• GlaxoSmithKline plc.
• Sanofi
• Novartis AG
• Pfizer Inc.
• Bayer AG
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Astellas Pharma Inc.
• Abbott
• Eli Lilly and Company.

The growing prevalence of bacterial infection is one of the major factors increasing the demand for antibiotics globally. However, expensive process of antibiotic development is likely to pose a negative impact on the market growth, which in turn will restrain the growth of the market during the forecast years.

Bacteria are microscopic and single-cell omnipresent organisms. Bacterial infection refers to the proliferation of harmful bacterial strains on or inside the human body. These microorganisms can infect any area of the body and may lead to severe consequences. A few of the indications of bacterial infections include pneumonia, meningitis, and food poisoning. Several commonly occurring pediatric bacterial infections are acute otitis media (AOM), sinusitis, bronchitis, upper respiratory tract infection, and pharyngitis.

The prevalence of infectious disease caused by bacteria is increasing day by day worldwide. According to a study published by the American Society for Microbiology (ASM) in 2019, 1.5-4.5 million infections across the world are caused by the Carbapenem-resistant bacterial strains belonging to the Enterobacteriaceae group every year. Additionally, the same risk factor leads to ~49,000 hospitalization cases in the US every year. Moreover, according to a study published by UNICEF, in 2018, pneumonia was the cause for ~1,755,000 deaths among children below the age of five; moreover, ~1,200,000 children lost their lives by diarrhea around the globe.

Further, according to a study published by the NCBI in 2018, campylobacterial infection, which is transmitted through the consumption of poultry, is one of the leading causes of bacterial foodborne infections in developed countries, which is causing a major economic burden. According to estimates given by the World Health Organization (WHO) in 2018, every year, ~33 million people die of campylobacteriosis worldwide.

Such potential increase in prevalence of bacterial infections is expected to continue to drive the growth of antibiotics market during the forecast period. Thus, the increasing prevalence of such drug-resistant bacteria compels the manufacturers and R&D faculties to come up with new variants of antimicrobials effective against the new, as well as old, bacterial strains, thereby fueling the growth of the antibiotics market.

The global antibiotics market is segmented into drug class and action mechanism. Based on drug class, the antibiotics market is segmented into sulfonamides, aminoglycosides, carbapenem, macrolides, fluoroquinolones, penicillin, cephalosporin, and others. The cephalosporin segment held the largest share of the market in 2019; whereas the fluoroquinolones segment is anticipated to register the highest CAGR in the market during the forecast period.

Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/2623844?utm_source=openpr.com&utm_medium=AG

Based on action mechanism, the antibiotics market is segmented into mycolic acid inhibitors, RNA synthesis inhibitors, DNA synthesis inhibitors, protein synthesis inhibitors, and cell wall synthesis inhibitors. The cell wall synthesis inhibitors segment held the largest share of the market in 2019; whereas the DNA synthesis inhibitors segment is estimated to register the highest CAGR in the market during the forecast period.

A few of the essential primary and secondary sources referred during the preparation of the report are, Food and Drug Administration, World Health Organization (WHO), Organization for Economic Co-operation and Development, and National Cancer Foundations

TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Antibiotics Market - By Drug Class
1.3.2 Global Antibiotics Market - By Action Mechanism
1.3.3 Global Antibiotics Market - By Geography
2. Antibiotics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Antibiotics Market - Market Landscape
4.1 Pest Analysis
4.1.1 North America- PEST Analysis
4.1.2 Europe- PEST Analysis
4.1.3 Asia Pacific
4.1.4 Middle East & Africa
4.1.5 South & Central America
5. Antibiotics Market - Key Market Dynamics
5.1 Market Drivers
6. Antibiotics Market - Global Analysis
6.1 Global Antibiotics Market Revenue Forecast And Analysis
6.2 Global Antibiotics Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Antibiotics Market Analysis - By Drug Class
8. Antibiotics Market - By Action Mechanism
9. Antibiotics Market - Geographic Analysis
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIBIOTICS MARKET
11. Antibiotics Market -Industry Landscape
12. COMPANY PROFILES
12.1 GlaxoSmithKline plc.
12.2 Sanofi
12.3 Novartis AG
12.4 Pfizer Inc.
12.5 Bayer AG
12.6 Johnson & Johnson Services, Inc.
12.7 Bristol-Myers Squibb Company
12.8 Astellas Pharma Inc.
12.9 Abbott
12.10 Eli Lilly and Company.
13. Appendix

buying decision on this premium report https://www.marketstudyreport.com/enquiry-before-buying/2623844?utm_source=openpr.com&utm_medium=AG

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.